🎉 M&A multiples are live!
Check it out!

ContextVision Valuation Multiples

Discover revenue and EBITDA valuation multiples for ContextVision and similar public comparables like Healius, Australian Clinical Labs, and Clarity Pharmaceuticals.

ContextVision Overview

About ContextVision

ContextVision AB is a medical technology company. It develops and sells image enhancement software for medical diagnosis and artificial intelligence. Its product portfolio includes image enhancement software for 2D/3D/4D (dimensional) ultrasound, magnetic resonance imaging (MRI), X-Ray, radiography, and mammography. its geographical segments are Asia, Europe, and America.


Founded

1983

HQ

Norway
Employees

40

Financials

LTM Revenue $14.1M

LTM EBITDA $4.8M

EV

$32.9M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

ContextVision Financials

ContextVision has a last 12-month revenue of $14.1M and a last 12-month EBITDA of $4.8M.

In the most recent fiscal year, ContextVision achieved revenue of $12.4M and an EBITDA of $3.8M.

ContextVision expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See ContextVision valuation multiples based on analyst estimates

ContextVision P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $12.5M $12.4M XXX XXX XXX
Gross Profit $11.3M $12.3M XXX XXX XXX
Gross Margin 90% 99% XXX XXX XXX
EBITDA $4.8M $3.8M XXX XXX XXX
EBITDA Margin 38% 31% XXX XXX XXX
Net Profit $2.7M $3.1M XXX XXX XXX
Net Margin 22% 25% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

ContextVision Stock Performance

As of April 15, 2025, ContextVision's stock price is NOK 5 (or $1).

ContextVision has current market cap of NOK 417M (or $39.4M), and EV of NOK 348M (or $32.9M).

See ContextVision trading valuation data

ContextVision Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$32.9M $39.4M XXX XXX XXX XXX $0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

ContextVision Valuation Multiples

As of April 15, 2025, ContextVision has market cap of $39.4M and EV of $32.9M.

ContextVision's trades at 2.4x LTM EV/Revenue multiple, and 7.3x LTM EBITDA.

Analysts estimate ContextVision's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for ContextVision and 10K+ public comps

ContextVision Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $32.9M XXX XXX XXX
EV/Revenue 2.7x XXX XXX XXX
EV/EBITDA 8.6x XXX XXX XXX
P/E 16.9x XXX XXX XXX
P/E/Growth 4.2x XXX XXX XXX
EV/FCF 11.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get ContextVision Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

ContextVision Valuation Multiples

ContextVision's NTM/LTM revenue growth is 7%

ContextVision's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, ContextVision's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate ContextVision's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for ContextVision and other 10K+ public comps

ContextVision Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -1% XXX XXX XXX XXX
EBITDA Margin 31% XXX XXX XXX XXX
EBITDA Growth -20% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 37% XXX XXX XXX XXX
Revenue per Employee $0.3M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 75% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

ContextVision Public Comps

See public comps and valuation multiples for Medical Imaging & Diagnostics and Healthcare Software comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Australian Clinical Labs XXX XXX XXX XXX XXX XXX
Clarity Pharmaceuticals XXX XXX XXX XXX XXX XXX
CurveBeam AI XXX XXX XXX XXX XXX XXX
Cyclopharm XXX XXX XXX XXX XXX XXX
Healius XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

ContextVision M&A and Investment Activity

ContextVision acquired  XXX companies to date.

Last acquisition by ContextVision was  XXXXXXXX, XXXXX XXXXX XXXXXX . ContextVision acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by ContextVision

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About ContextVision

When was ContextVision founded? ContextVision was founded in 1983.
Where is ContextVision headquartered? ContextVision is headquartered in Norway.
How many employees does ContextVision have? As of today, ContextVision has 40 employees.
Who is the CEO of ContextVision? ContextVision's CEO is Mr. Gerald Potzsch.
Is ContextVision publicy listed? Yes, ContextVision is a public company listed on OSL.
What is the stock symbol of ContextVision? ContextVision trades under CONTX ticker.
When did ContextVision go public? ContextVision went public in 1997.
Who are competitors of ContextVision? Similar companies to ContextVision include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm.
What is the current market cap of ContextVision? ContextVision's current market cap is $39.4M
What is the current revenue of ContextVision? ContextVision's last 12-month revenue is $14.1M.
What is the current EBITDA of ContextVision? ContextVision's last 12-month EBITDA is $4.8M.
What is the current EV/Revenue multiple of ContextVision? Current revenue multiple of ContextVision is 2.4x.
What is the current EV/EBITDA multiple of ContextVision? Current EBITDA multiple of ContextVision is 7.3x.
What is the current revenue growth of ContextVision? ContextVision revenue growth between 2023 and 2024 was -1%.
Is ContextVision profitable? Yes, ContextVision is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.